Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...

Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ...

Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...

The analysts wrote that the R&D savings associated with restructuring, plus reduced separation-related activities (from Embecta’s spin-off from BD), enable the company ... The company recently ...

CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, ...

The board of directors of Franklin Lakes-based, global medical technology company BD, has unanimously authorized BD ...

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...

Expanding upon their ongoing collaboration, WILDSIDE Yohji Yamamoto and NEEDLES have come together to reinterpret NEEDLES’ classic Cowboy jacket and pants. The Cowboy jacket features a snap ...

BD has increased its manufacturing capacity for critical medical supplies, including syringes, needles and IV catheters to help meet the needs of the U.S. health system. The move is part of BD’s ...

The Samsung Galaxy S25 Ultra S Pen no longer supports Bluetooth connectivity, removing features like Air Actions. Samsung says the change was made due to low user engagement and suggests using ...

Shortly after sunrise, John Gobbi stepped gingerly across a sidewalk in Boston’s South End strewn with dirty and discarded drug needles. Every so often his work boots crushed another syringe ...